AC260584 is primarily utilized in the field of neuroscience research due to its role as a selective antagonist of the muscarinic acetylcholine receptor subtype M1. This compound is particularly valuable in studying the physiological and pathological functions of M1 receptors in the central nervous system. Researchers employ AC260584 to investigate its potential therapeutic effects in neurological disorders such as Alzheimer's disease, schizophrenia, and Parkinson's disease. By blocking M1 receptors, it helps to elucidate their involvement in cognitive processes, memory, and motor control. Additionally, AC260584 is used in preclinical studies to explore its impact on synaptic plasticity and neuronal signaling pathways, providing insights into the development of targeted treatments for brain-related conditions.